Frieberg's Infarction (Avascular Necrosis of the Second Metatarsal Head)

Comprehensive Guide to Freiberg’s Infarction (Avascular Necrosis of the Second Metatarsal Head)

1. Introduction and Overview

Freiberg’s Infarction, technically categorized as osteochondrosis of the second metatarsal head, is a rare, localized form of avascular necrosis (AVN). First described by Alfred Freiberg in 1914, this condition involves the collapse of the subchondral bone of the metatarsal head, typically occurring during adolescent growth spurts.

While the second metatarsal is the primary site of involvement due to its unique anatomical position and mechanical stress profile, the condition can occasionally affect the third or fourth metatarsals. If left untreated, the progressive collapse of the articular surface leads to secondary degenerative joint disease (osteoarthritis) of the metatarsophalangeal (MTP) joint, resulting in chronic pain, functional impairment, and significant morbidity.

2. Etiology and Pathophysiology

The exact etiology of Freiberg’s Infarction remains multifactorial, involving a synergistic interplay between mechanical trauma and vascular compromise.

The Mechanical Hypothesis

The second metatarsal is inherently the longest and most rigid of the metatarsals. It is fixed firmly at the base by the cuneiforms, making it the primary point of force distribution during the "toe-off" phase of gait. Repetitive microtrauma—often exacerbated by high-impact sports, pointe ballet dancing, or improper footwear—leads to stress fractures at the subchondral level.

The Vascular Hypothesis

The blood supply to the second metatarsal head is precarious. It relies on terminal end-arteries that are susceptible to disruption during rapid skeletal maturation. When repetitive stress exceeds the repair capacity of the epiphyseal plate, the resulting ischemia leads to the death of subchondral osteocytes.

Pathophysiological Progression

1. Ischemic Phase: Disruption of blood supply leads to osteocyte necrosis.
2. Resorption Phase: The body attempts to revascularize the area, leading to bone resorption and structural weakening.
3. Collapse Phase: Under the pressure of weight-bearing, the necrotic, weakened subchondral bone collapses (the "infarction").
4. Repair/Deformity Phase: The joint surface flattens, often resulting in an enlarged, misshapen metatarsal head that inhibits proper joint mechanics.

3. Clinical Staging and Grading (Smillie Classification)

The Smillie system is the gold standard for staging Freiberg’s Infarction, providing a roadmap for both prognosis and surgical intervention.

4. Clinical Presentation and Diagnosis

Standard Presentation

Patients typically present in their mid-to-late adolescence, though adult presentations are documented. Key symptoms include:
* Localized Pain: Focal tenderness over the second MTP joint.
* Activity-Related Exacerbation: Pain increases during ambulation, jumping, or wearing restrictive shoes.
* Swelling and Edema: Often localized to the dorsal aspect of the forefoot.
* Restricted ROM: Progressive stiffness in the MTP joint, particularly in dorsiflexion.

Diagnostic Modalities

• Radiography (X-ray): Initial imaging often reveals widening of the MTP joint space, flattening of the metatarsal head, and eventual sclerosis.
• Magnetic Resonance Imaging (MRI): The gold standard for early detection. MRI can identify marrow edema and ischemia before structural collapse is visible on plain film.
• Bone Scintigraphy: Rarely used today, but can show increased uptake in the affected area in early stages.

Differential Diagnosis

It is critical to distinguish Freiberg’s from other forefoot pathologies:
* Morton’s Neuroma: Presents with burning, tingling, and numbness (interdigital), whereas Freiberg’s is deep, bony pain.
* Stress Fractures: Usually diaphyseal rather than epiphyseal.
* Synovitis/Capsulitis: Lacks the bony necrotic changes seen on imaging.
* Rheumatoid Arthritis: Usually polyarticular and associated with systemic markers (RF, Anti-CCP).

5. Clinical Management and Therapeutic Strategies

Treatment focuses on offloading the joint to allow for revascularization and preventing secondary osteoarthritis.

Conservative Management (Stages I-II)

• Activity Modification: Cessation of high-impact sports for 4–6 weeks.
• Offloading: Use of a stiff-soled shoe, metatarsal pads, or a short-leg walking boot (CAM boot) to redistribute pressure away from the second metatarsal head.
• NSAIDs: For pain management and reduction of inflammation.
• Physical Therapy: Focus on maintaining ROM in adjacent joints and strengthening intrinsic foot muscles.

Surgical Intervention (Stages III-V)

When conservative measures fail or the deformity is severe, surgery is indicated:
* Debridement/Loose Body Removal: Arthroscopic or open removal of intra-articular debris.
* Core Decompression: Aimed at stimulating revascularization in early, non-collapsed stages.
* Dorsal Closing Wedge Osteotomy: Used to rotate the healthy articular cartilage into the weight-bearing zone of the joint.
* Arthroplasty/Arthrodesis: Reserved for end-stage (Stage V) cases where secondary arthritis is debilitating.

6. Risks, Side Effects, and Contraindications

• Risks of Conservative Care: Prolonged immobilization can lead to muscle atrophy and stiffness.
• Surgical Risks: Infection, non-union of osteotomy sites, transfer metatarsalgia (where pain shifts to the 3rd or 4th metatarsals), and nerve injury.
• Contraindications: Corticosteroid injections into the MTP joint are generally contraindicated, as they may accelerate cartilage degradation and worsen the necrotic process.

7. Long-term Prognosis

The prognosis is largely dependent on the stage of diagnosis. Early intervention (Stage I/II) often results in a full functional recovery. However, once Stage III or IV is reached, the prognosis is guarded, as the articular surface is permanently altered. Most patients can lead active lives with appropriate footwear modifications, though high-impact activities may require permanent restriction to prevent rapid progression to end-stage osteoarthritis.

8. Frequently Asked Questions (FAQ)

1. Is Freiberg’s Infarction genetic?
There is no direct genetic inheritance pattern, though some anatomical predispositions (e.g., a long second metatarsal) may be hereditary.

2. Can I continue to play sports with Freiberg’s?
During the acute phase, high-impact sports must be suspended. After healing, a gradual return is possible, provided the patient uses orthotics and appropriate footwear.

3. Does this condition affect both feet?
It is usually unilateral, but bilateral involvement occurs in approximately 10% of cases.

4. Will I need surgery?
Not necessarily. Many early-stage cases resolve with conservative offloading and activity modification.

5. How long does the healing process take?
Conservative management typically requires 3 to 6 months of dedicated offloading. Surgical recovery varies from 3 to 9 months depending on the procedure.

6. What is "transfer metatarsalgia"?
This is a common complication where, after surgery or due to the deformity, the load is shifted to the adjacent metatarsals, causing pain in those areas.

7. Can children get Freiberg’s?
Yes, it is most common in adolescents during peak growth periods, though it can occur in pre-teens.

8. Are women more at risk than men?
Yes, epidemiological data suggests a female-to-male ratio of approximately 3:1 to 5:1, likely due to footwear choices and earlier skeletal maturation.

9. What kind of shoes should I wear?
Shoes with a rigid sole, a wide toe box, and a metatarsal pad are highly recommended to reduce the load on the second MTP joint.

10. Is this the same as a stress fracture?
No. While a stress fracture is a break in the bone, Freiberg’s is a death of bone tissue (necrosis) that leads to structural failure. However, a stress fracture can sometimes be the inciting event for Freiberg’s.

9. Conclusion

Freiberg’s Infarction represents a complex challenge in orthopedic medicine. Because it mimics common forefoot pain, clinical vigilance is required for any adolescent presenting with chronic metatarsal head tenderness. Early diagnosis via MRI and aggressive offloading remain the cornerstones of successful management. By understanding the mechanical and vascular nature of the pathology, clinicians can effectively guide patients toward outcomes that preserve joint function and improve long-term quality of life.

Disclaimer: This document is for educational purposes only and does not constitute medical advice. Always consult with an orthopedic specialist or podiatric surgeon for clinical diagnosis and treatment planning.